Advertisement
Screener

KYTHERA BIOPHARMACEUTICALS INC Increase (Decrease) in Accounts Payable and Accrued Liabilities

KYTHERA BIOPHARMACEUTICALS INC Increase (Decrease) in Accounts Payable and Accrued Liabilities

KYTHERA BIOPHARMACEUTICALS INC reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $11.55 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2015-08-06

  • KYTHERA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2015-06-30 was $9.93M, a 4967.86% increase year-over-year.
  • KYTHERA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2015-03-31 was $1.62M.
  • KYTHERA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-12-31 was $3.13M, a 1086.74% increase year-over-year.
  • KYTHERA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-09-30 was $3.18M, a 72.76% increase year-over-year.
  • KYTHERA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2014 was $4.60M, a 558.08% increase from fiscal 2013.
  • KYTHERA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2013 was $699.00K, a 78.18% decline from fiscal 2012.
  • KYTHERA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was $3.20M, a 3903.75% increase from fiscal 2011.
  • KYTHERA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was $80.00K, a 97.26% decline from fiscal 2010.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month
2015-06-30$9.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$11.55M
10-Q · filed 2015-08-06
$14.68M
derived: sum of 3 quarters · filed 2015-08-06
$17.86M
derived: sum of 4 quarters · filed 2015-08-06
2015-03-31$1.62M
10-Q · filed 2015-05-07
$4.75M
derived: sum of 2 quarters · filed 2015-05-07
$7.93M
derived: sum of 3 quarters · filed 2015-05-07
$8.12M
derived: sum of 4 quarters · filed 2015-08-06
2014-12-31$3.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$6.31M
derived: sum of 2 quarters · filed 2015-03-02
$6.51M
derived: sum of 3 quarters · filed 2015-08-06
$4.60M
10-K · filed 2015-03-02
2014-09-30$3.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$3.37M
derived: sum of 2 quarters · filed 2015-08-06
$1.47M
10-Q · filed 2014-11-10
$1.73M
derived: sum of 4 quarters · filed 2015-08-06
2014-06-30$196.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$1.71M
10-Q · filed 2015-08-06
-$1.45M
derived: sum of 3 quarters · filed 2015-08-06
$393.00K
derived: sum of 4 quarters · filed 2015-08-06
2014-03-31-$1.91M
10-Q · filed 2015-05-07
-$1.64M
derived: sum of 2 quarters · filed 2015-05-07
$197.00K
derived: sum of 3 quarters · filed 2015-05-07
$100.00K
derived: sum of 4 quarters · filed 2015-05-07
2013-12-31$264.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$2.10M
derived: sum of 2 quarters · filed 2015-03-02
$2.01M
derived: sum of 3 quarters · filed 2015-03-02
$699.00K
10-K · filed 2015-03-02
2013-09-30$1.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$1.74M
derived: sum of 2 quarters · filed 2014-11-10
$435.00K
10-Q · filed 2014-11-10
$2.62M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$97.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
-$1.40M
10-Q · filed 2014-08-07
$778.00K
derived: sum of 3 quarters · filed 2015-03-02
$3.18M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31-$1.31M
10-Q · filed 2014-05-08
$875.00K
derived: sum of 2 quarters · filed 2015-03-02
$3.28M
derived: sum of 3 quarters · filed 2015-03-02
$1.41M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31$2.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$4.59M
derived: sum of 2 quarters · filed 2015-03-02
$2.71M
derived: sum of 3 quarters · filed 2015-03-02
$3.20M
10-K · filed 2015-03-02
2012-09-30$2.40M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-14
$531.00K
derived: sum of 2 quarters · filed 2013-11-14
$1.02M
10-Q · filed 2013-11-14
$2.61M
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30-$1.87M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-09-27
-$1.38M
10-Q/A · filed 2013-09-27
$201.00K
derived: sum of 3 quarters · filed 2014-03-17
2012-03-31$490.00K
10-Q/A · filed 2013-09-27
$2.08M
derived: sum of 2 quarters · filed 2014-03-17
2011-12-31$1.58M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-17
$80.00K
10-K · filed 2014-03-17
2011-09-30-$1.50M
10-Q/A · filed 2012-12-03
2010-12-31$2.92M
10-K/A · filed 2013-09-27